Senior insider sale
President, Chief Medical Off at TRAWS PHARMA, INC. — senior position signals high conviction
$14.0K
17.94K shares
What this filing means
FRUCHTMAN STEVEN M plans to sell 17.94K shares of TRAWS PHARMA, INC. valued at approximately $14.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/14/2024ACC: 0001950047-24-002323
Officer· President, Chief Medical Off
Since Jul 2018
17.94K
Shares to sell
$14.0K
Approx. market value
8.73K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
3/13/2024
8.73KTotal acquired8.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2024 | Restricted stock vesting under a registered plan Not Applicable | 8.73K | — |
| Total | 8.73K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.21K
Market value
$6.2K
2/8/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.73K
Market value
$7.9K
3/14/2024
Total
Units
17.94K
Value
$14.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/8/2024 | 9.21K | $6.2K | — | Completed |
| Planned — Approximate Date | ||||
3/14/2024 | 8.73K | $7.9K | NASDAQ | Planned |
| Total | 17.94K | $14.0K | ||